185 related articles for article (PubMed ID: 21420160)
1. Reshaping the Bet v 1 fold modulates T(H) polarization.
Wallner M; Hauser M; Himly M; Zaborsky N; Mutschlechner S; Harrer A; Asam C; Pichler U; van Ree R; Briza P; Thalhamer J; Bohle B; Achatz G; Ferreira F
J Allergy Clin Immunol; 2011 Jun; 127(6):1571-8.e9. PubMed ID: 21420160
[TBL] [Abstract][Full Text] [Related]
2.
Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
Front Immunol; 2020; 11():2118. PubMed ID: 33013894
[TBL] [Abstract][Full Text] [Related]
3. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
[TBL] [Abstract][Full Text] [Related]
4. A hypoallergenic variant of the major birch pollen allergen shows distinct characteristics in antigen processing and T-cell activation.
Kitzmüller C; Wallner M; Deifl S; Mutschlechner S; Walterskirchen C; Zlabinger GJ; Ferreira F; Bohle B
Allergy; 2012 Nov; 67(11):1375-82. PubMed ID: 22973879
[TBL] [Abstract][Full Text] [Related]
5. Epitope grafting, re-creating a conformational Bet v 1 antibody epitope on the surface of the homologous apple allergen Mal d 1.
Holm J; Ferreras M; Ipsen H; Würtzen PA; Gajhede M; Larsen JN; Lund K; Spangfort MD
J Biol Chem; 2011 May; 286(20):17569-78. PubMed ID: 21454600
[TBL] [Abstract][Full Text] [Related]
6. Chimeras of Bet v 1 and Api g 1 reveal heterogeneous IgE responses in patients with birch pollen allergy.
Gepp B; Lengger N; Bublin M; Hemmer W; Breiteneder H; Radauer C
J Allergy Clin Immunol; 2014 Jul; 134(1):188-94. PubMed ID: 24529686
[TBL] [Abstract][Full Text] [Related]
7. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
8. The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
Smole U; Radauer C; Lengger N; Svoboda M; Rigby N; Bublin M; Gaier S; Hoffmann-Sommergruber K; Jensen-Jarolim E; Mechtcheriakova D; Breiteneder H
PLoS One; 2015; 10(1):e0117904. PubMed ID: 25635684
[TBL] [Abstract][Full Text] [Related]
9. Bet v 1--a Trojan horse for small ligands boosting allergic sensitization?
Asam C; Batista AL; Moraes AH; de Paula VS; Almeida FC; Aglas L; Kitzmüller C; Bohle B; Ebner C; Ferreira F; Wallner M; Valente AP
Clin Exp Allergy; 2014 Aug; 44(8):1083-93. PubMed ID: 24979350
[TBL] [Abstract][Full Text] [Related]
10. Allergen hybrids - next generation vaccines for Fagales pollen immunotherapy.
Pichler U; Hauser M; Hofer H; Himly M; Hoflehner E; Steiner M; Mutschlechner S; Hufnagl K; Ebner C; Mari A; Briza P; Bohle B; Wiedermann U; Ferreira F; Wallner M
Clin Exp Allergy; 2014 Mar; 44(3):438-49. PubMed ID: 24330218
[TBL] [Abstract][Full Text] [Related]
11. Human TCR transgenic Bet v 1-specific Th1 cells suppress the effector function of Bet v 1-specific Th2 cells.
Neunkirchner A; Leb-Reichl VM; Schmetterer KG; Mutschlechner S; Kueng HJ; Haiderer D; Schuch K; Wallner M; Jahn-Schmid B; Bohle B; Pickl WF
J Immunol; 2011 Oct; 187(8):4077-87. PubMed ID: 21908735
[TBL] [Abstract][Full Text] [Related]
12. Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001.
Smole U; Balazs N; Hoffmann-Sommergruber K; Radauer C; Hafner C; Wallner M; Ferreira F; Grössinger R; de Jong EC; Wagner S; Breiteneder H
Immunobiology; 2010 Nov; 215(11):903-9. PubMed ID: 20005001
[TBL] [Abstract][Full Text] [Related]
13. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
[TBL] [Abstract][Full Text] [Related]
14. Bet v 1 and its homologous food allergen Api g 1 stimulate dendritic cells from birch pollen-allergic individuals to induce different Th-cell polarization.
Smole U; Wagner S; Balazs N; Radauer C; Bublin M; Allmaier G; Hoffmann-Sommergruber K; Breiteneder H
Allergy; 2010 Nov; 65(11):1388-96. PubMed ID: 20557297
[TBL] [Abstract][Full Text] [Related]
15. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
16. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
Hoflehner E; Hufnagl K; Schabussova I; Jasinska J; Hoffmann-Sommergruber K; Bohle B; Maizels RM; Wiedermann U
PLoS One; 2012; 7(6):e39409. PubMed ID: 22768077
[TBL] [Abstract][Full Text] [Related]
17. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen.
Son DY; Scheurer S; Hoffmann A; Haustein D; Vieths S
Eur J Nutr; 1999 Aug; 38(4):201-15. PubMed ID: 10502033
[TBL] [Abstract][Full Text] [Related]
18. Critical role of mammalian target of rapamycin for IL-10 dendritic cell induction by a flagellin A conjugate in preventing allergic sensitization.
Schülke S; Fiedler AH; Junker AC; Flaczyk A; Wolfheimer S; Wangorsch A; Heinz A; Beckert H; Nagl B; Bohle B; Vieths S; Toda M; Scheurer S
J Allergy Clin Immunol; 2018 May; 141(5):1786-1798.e11. PubMed ID: 28886863
[TBL] [Abstract][Full Text] [Related]
19. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
20. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
